Covington & Burling (Washington)

Deborah A. Garza

Covington & Burling (Washington)
Lawyer (Partner)

Deborah Garza is co-chair of the firm’s Antitrust and Competition Law Practice Group. With more than 30 years of experience in both the private and public sectors, Ms. Garza has been involved in some of the largest antitrust matters in the last thirty years, including the merger of Exxon and Mobil, the U.S. Government’s suit against Microsoft, the USFL suit against the NFL, and many other litigation and regulatory matters on behalf of Fortune 500 companies. Ms. Garza joined Covington in 2009 from the Justice Department, where she served as Acting Assistant Attorney General in charge of the Antitrust Division. From May 2007 through November 2008, Ms. Garza was Deputy Assistant Attorney General for Regulatory Affairs, overseeing matters in the telecommunications, transportation, energy, health care, agricultural, insurance, broadcast radio, real estate, and other industries. During two prior tours of service during the 1980s, Ms. Garza served as a Special Assistant and as Chief of Staff and Counselor to the Assistant Attorney General in charge of the Antitrust Division. In 2004, Ms. Garza was appointed by President George W. Bush to chair the Antitrust Modernization Commission (“AMC”), a bi-partisan blue-ribbon panel created by Congress to study and report to the President and Congress on the state of antitrust enforcement in the United States. Ms. Garza has been a leader in the Antitrust Section of the American Bar Association. In addition, in 2005, she helped found the Diversity Network, a collaboration of Washington, DC, law firms to provide networking opportunities and access to community leaders for lawyers of diverse backgrounds.

Distinctions

Linked authors

Covington & Burling (Washington)
Covington & Burling (London)
Covington & Burling (Brussels)
Covington & Burling (Washington)
Covington & Burling (Washington)

Articles

164 Bulletin

Thomas Barnett, Deborah A. Garza, John D. Graubert, James R. Dean, James J. O’Connell, Ross A. Demain The US DoJ imposes a $11 million fine for merger notification violation on an investment company (ValueAct)

14

Yesterday, the Antitrust Division of the Department of Justice (“DOJ”) announced that it has settled its lawsuit against ValueAct Capital Management L.P. (“ValueAct”) for violating the Hart- Scott-Rodino Antitrust Improvements Act of 1976 (the “HSR Act”). The settlement is noteworthy for two (...)

Thomas Barnett, Deborah A. Garza, John D. Graubert, Timothy C. Hester, Andrew D. Lazerow, John W. Nields, James J. O’Connell The US FTC brings a lawsuit in the pharmaceutical sector for monopolization based on patent litigation (AndroGel II)

32

The Federal Trade Commission has brought its first suit alleging anticompetitive conduct in connection with the prosecution and settlement of pharmaceutical patent litigation since the Supreme Court’s June 2013 decision in FTC v. Actavis. Although two commissioners dissented from the decision to (...)

Thomas Barnett, Deborah A. Garza, Derek Ludwin, James J. O’Connell, Alan M. Wiseman The US Court of Appeals for the Seventh Circuit rules that a foreign anticompetitive conduct may be subject to US antitrust laws (Minn-Chem / Agrium)

22

Yesterday, the influential Court of Appeals for the Seventh Circuit, sitting en banc, held that foreign anticompetitive conduct can be regulated by U.S. antitrust law if it has “a reasonably proximate causal nexus” with an injury to a U.S. purchaser. The Seventh Circuit explicitly rejected the (...)

Thomas Barnett, James R. Dean, Deborah A. Garza, John D. Graubert, James J. O’Connell, Anita F. Stork, David W. Addis The US DoJ and FTC announce changes to the HSR Act merger notification process and transaction report form submitted by companies

23

On July 7, 2011, the Federal Trade Commission and the Department of Justice (“the Agencies”) announced significant changes to the form and accompanying materials that companies must submit when reporting transactions under the Hart-Scott-Rodino Antitrust Improvements Act (“HSR Act”). Although the (...)

Thomas Barnett, James R. Dean, Deborah A. Garza, John D. Graubert, Timothy C. Hester, James J. O’Connell The US FTC and DoJ issue revised horizontal merger guidelines

20

Last week, the U.S. Justice Department (“DOJ”) and Federal Trade Commission (“FTC”) (together, the “Agencies”) issued revised Horizontal Merger Guidelines (the “Guidelines”) describing how the Agencies seek to determine whether a merger of competing companies will substantially lessen competition. The (...)

Thomas Barnett, James R. Dean, Deborah A. Garza, John D. Graubert, Timothy C. Hester, James J. O’Connell The US District Court for the Eastern District of Pennsylvania holds that reverse payments cases will proceed to discovery in a patent litigation in the pharmaceutical sector (Cephalon)

31

In the latest development in the Federal Trade Commission’s efforts to challenge Hatch-Waxman patent litigation settlements, earlier this week a federal district court in Pennsylvania denied in part defendants’ motions to dismiss antitrust complaints challenging a series of such settlements. The (...)

Books

Send a message